P
Porton Pharma Solutions Ltd
SZSE:300363
Porton Pharma Solutions Ltd
SZSE:300363
Price:
20.66
CNY
-1.24%
Market Closed
Market Cap:
¥11.2B
Relative Value
The Relative Value of one Porton Pharma Solutions Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 20.66 CNY, Porton Pharma Solutions Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Porton Pharma Solutions Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Porton Pharma Solutions Ltd Competitors
Porton Pharma Solutions Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
P
|
Porton Pharma Solutions Ltd
SZSE:300363
|
11.3B CNY | 3.3 | -8 002.1 | 190.9 | 190.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
924.3B USD | 14.2 | 44.8 | 30.2 | 32.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
575.3B USD | 6.1 | 21.5 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
281.3B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
240.6B CHF | 5.5 | 22.1 | 13.7 | 17.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
230.1B GBP | 5.3 | 30.2 | 16.7 | 23.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.9B USD | 4.4 | 15.7 | 9.8 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.8 | 8 | 9.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.3B USD | 2.4 | 19.5 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.5 | 17.3 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
